Cardiovascular GLP-1 indication approval 2026: Neither in 2026
47%YES chance
Yes
47%
No
53%
Now 47.1%
Resolution
Resolves to the first GLP-1 to win an additional cardiovascular indication from FDA in 2026.
Source: https://www.fda.gov/
Resolves by Apr 8, 2027.
Recent trades
- NO@drewhayes15.2 sh@ 47%8 SP
- NO@skylercarrillo43.1 sh@ 48%22 SP
Top holders
YES holders
No holders yet.
NO holders
No holders yet.
News
Refreshed every 6 hours
No news yet. Endcap's news crawler refreshes every 6 hours.